FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Endonovo Therapeutics announces its collaboration with Major Universities for the Evaluation of SofPulse® for Orthopedic Surgeries.”
Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced their SofPulse® device is being evaluated at major universities for orthopedic surgeries. SofPulse® is Endonovo’s FDA-Cleared, non-invasive device utilized for the reduction of postoperative pain and edema. SofPulse® represents a low-cost drug-free solution for reducing opioid usage, accelerating patient recovery and preventing opioid addiction following surgical procedures. This non-invasive and non-pharmacologic therapy has no known side effects and presents no potential for overdose or dependency as SofPulse® is not reliant on any narcotic to produce pain and edema reduction. SofPulse® has been effectively utilized and studied extensively in soft tissue postoperative pain management showing significant clinically proven results for the reduction of postoperative pain and edema. Learn more at www.sofpulse.com.
About Endonovo Therapeutics Endonovo Therapeutics, Inc. is a commercial-stage developer of noninvasive wearable Electroceuticals® therapeutic devices. The Company’s current portfolio of commercial and clinical-stage wearable Electroceuticals® therapeutic devices addresses wound healing, pain, post-surgical pain and edema, cardiovascular disease, chronic kidney disease, and central nervous system (CNS) disorders, including traumatic brain injury (TBI), acute concussions, post-concussion syndrome and multiple sclerosis. The Company’s noninvasive Electroceutical® therapeutic device, SofPulse®, which uses pulsed short-wave radiofrequency at 27.12 MHz, has been FDA-cleared and CE marked for the palliative treatment of soft tissue injuries and post-operative pain and edema and has CMS national coverage for the treatment of chronic wounds. The Company’s current portfolio of preclinical-stage Electroceuticals® therapeutic devices addresses chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke. The Company’s noninvasive, wearable Electroceuticals® therapeutic devices work by restoring key electrochemical processes that initiate anti-inflammatory and growth factor cascades necessary for healing to occur. www.endonovo.com.
As technology evolves to increase productivity and eliminate or reduce human error, several major industries are expected to undergo significant changes. The medical device industry, for example, is expected to enter a new phase thanks to several advancements such as the Internet of Things (IoT), big data analytics, augmented reality devices and other technologies that are only now reaching maturity or will promptly. Overall, the medical technology industry encompasses numerous segments such as instruments, apparatuses, and machines that are used in the prevention, diagnosis or treatment of illness or disease. Moreover, such devices can help in detecting, measuring, restoring, correcting, or modifying the structure or function of the body for some health resolutions. Additionally, internet-connected devices, ranging from hospital imaging equipment to implantable pacemakers and infusion pumps, help healthcare providers and patients in a variety of tasks, such as monitoring vitals, improving diagnostics, regulating dosages, and more. According to Synopsys, a computer integrated systems design company, U.S. hospitals have an average of 10-15 connected medical devices per bed. As such, the global medical devices market reached a value nearly USD 423.8 Billion in 2018, having grown at a compound annual growth rate (CAGR) of 5.28% since 2014. Furthermore, it is expected to grow at a CAGR of 5.33% to nearly USD 521.64 Billion by 2022, according to data published by Research and Markets.
The orthopedic medical devices segment is a growing and vibrant section of the medical devices industry. High prevalence of orthopedic conditions such as degenerative bone disease coupled with a rising geriatric population and a number of road accidents are anticipated to drive the market. Additionally, early onset of musculoskeletal conditions triggered by obesity and sedentary lifestyle are expected to boost its growth as well. On the basis of products, the market is categorized into accessories and surgical devices. The surgical device segment is further divided into drill guide, custom clamps, guide tubes, screw drivers, and distracters, among others. The accessories segment covers products such as braces, arthroscopes, and other consumables. Currently available trauma management techniques are incapable of restoring body parts successfully due to the lack of efficient surgical tools. As a result, manufacturers are investing significantly in Research and Development (R&D) to develop innovative and efficient devices. Overall, the global orthopedic devices market size was valued at USD 36.1 Billion in 2017. It is anticipated to expand at a CAGR of 3.1% over the forecast period of 2018 – 2026, according to Grand View Research.
For more information, please visit: Endonovo Therapeutics, Inc.
For more corporate news on Endonovo Therapeutics, Inc., check out the Buzz on the Street
About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.